logo
Technology Provides Aid in Fight Against Workplace Violence

Technology Provides Aid in Fight Against Workplace Violence

Medscape23-07-2025
In American hospitals, the corporate buzzword 'employee engagement' likely means something different than it does at the local widget company. No, in healthcare it first and foremost means keeping clinicians and all the caregivers in the hospital environment safe.
The most recent data released from the US Bureau of Labor Statistics showed that healthcare workers accounted for 73% of all nonfatal workplace injuries and illnesses due to violence in 2018. This was a rate of 10.4 incidents per 10,000 workers, and the number of incidents showed steady increases since 2011. These figures do not account for the fraught period around the pandemic, during which time one study conducted in Egypt reported that more than half the healthcare workers who responded had been subjected to some sort of abuse on the job, whereas another conducted in Pakistan found that nearly 40% of emergency department doctors and nurses reported at least one episode of violence.
With figures like these, not to mention the profession-wide burnout crisis, healthcare facilities all over the world are seeking out new approaches to keep providers safe. Northeast Georgia Health System, headquartered in Gainesville, Georgia, and Holyoke Medical Center, based in Holyoke, Massachusetts, are using a Bluetooth Low Energy ( BLE) system to do just that — and more.
Tool Protects 10,000 Staff Members in Northeast Georgia
With 950 beds and 10,000 medical staff members to protect at five locations, Northeast Georgia Health System Chief Information Officer Chris Paravate had a security challenge on his hands.
'When patients come to us, particularly in the emergency room and inpatient, they were not only bringing their medical condition, they're bringing everything with them. Their problems, their issues, their anxiety, their fear, their families, their socioeconomic problems come in our front door, and people are the most vulnerable when they are in that setting,' Paravate said. 'Sometimes their actions are not so favorable, and we want our patients and our employees and our staff to feel safe.'
In 2021, Paravate turned to Poland-founded, New York-based Kontakt.io and their BLE badging system to enhance security at their locations. The device contains a portable duress button that provides real-time location services, can be integrated within existing security and nursing workflows, and is able to be pressed discreetly — much more so than the old system of pulling a cord or rope to trigger an alert system, or even reaching for and pressing the emergency button on a cell phone, either of which may serve to only exacerbate a dangerous situation.
Paravate said he left his first meeting with Kontakt.io's CEO and put some sample devices in the hands of one of the charge nurses on duty in the emergency department of their Gainesville facility, and the reaction was immediate.
'I said, 'Would you wear this?' And she took the badge and put it on and said, 'I'll try it. What does it do?'' Paravate said. 'I said, 'Well, it's got a button on the back, and you can press it if you need help.' She said, 'Oh, that'd be cool.''
Nurses are understandably picky about their gear and notorious for immediately sensing anything that will slow them down or get in the way of providing care. This reception was what Paravate had been looking for in a technology-based approach to workplace violence reduction.
'(You usually can't take) that type of innovation and…talk with someone who has journeyed through that, who literally was 50 steps from four trauma rooms, who's sitting in the core of the third largest emergency room in the state, and…get that reaction,' Paravate said.
The charge nurse wanted to know when the rest of the staff would get the same tool and how it works and wanted to know that if she pushed the button, someone would actually come help, he said.
'It was never about, well, you're gonna tag me or you're gonna track me,' he said. 'It was, 'Wow, you'd invest in technology for me to ensure that I was safe.''
Paravate had also been looking for a system that could be used for multiple purposes. At Northeast Georgia Health System, they are using the badging system to track patients to accurately deploy physician resources as well. For example, it can ensure that physicians only round on patients who are in their rooms so as not to waste providers' time when they could be caring for others. Paravate said these data are being used over time to forecast and anticipate staffing needs. Overall, Northeast Georgia Health System reported an estimated $10.2 million return on investment in the first year of deployment of the badging system's initial use case, which is a factor of 20x on their initial spend.
What Is BLE?
Bluetooth is the wireless technology familiar to most people for its use in earbuds, car stereos, and the like. This 'digital handshake' enables a variety of wireless devices to connect and interact using radio waves to transmit information. When two Bluetooth-enabled devices are in proximity, they can detect each other and initiate a connection. That's called pairing, where devices exchange unique security codes to establish a secure link; once paired, they remember each other for future connections.
Instead of maintaining a continuous connection, BLE devices send small packets of data intermittently, sleeping when not transmitting or receiving data to conserve power. These devices manage their transmissions through a system of what are called advertising channels — not advertising like on television but advertising in the 'Hey, it's me, I'm here,' sense: A peripheral device, like a sensor in a badge in this case, will 'advertise' its presence by periodically sending out small data packets. A central device, such as a smartphone, can then listen for these advertisements and initiate a connection if it needs more information.
Once a connection is established, BLE maintains its energy efficiency by using a pared-down client-server architecture known as the Generic Attribute Profile. The peripheral device acts as the server, holding data in a standardized format of services and characteristics. The central device, or client, can then read or write these data as needed. Using asynchronous communication, the client only requests data when necessary, and the server only sends updates when new information is available. With BLE's very fast connection setup times and short data packets, this ensures that the radio is active for the minimum possible duration, extending the battery life of devices so that they often last months or even years on a single coin cell battery.
The Competitive Landscape in BLE
Several of Kontakt.io's competitors in the staff duress badging sector include BLE in their badging makeup. These competitors include the following companies:
AiRISTA Flow, which specializes in RTLS solutions across many industries. Their products include BLE-based tags and infrastructure for healthcare. They focus on improving operational efficiency, patient safety, and asset utilization.
BeaconTrax, a Canadian company that specializes in beacon-based technologies powered by BLE that offers staff distress systems for the healthcare industry. Its systems include panic buttons and wristbands.
BlueUp, an Italian company that designs and produces Local Positioning Systems based on BLE technology, as well as a wide range of other systems. They offer solutions for localization, tracking, and asset management in healthcare facilities, as well as for manufacturing and logistics operations, and their products include badges and wearable devices.
CenTrak, which has a wide range of tags for both patients and staff, some of which include BLE in their technology package, often combined with Wi-Fi and their proprietary Gen2IR for accuracy. They offer solutions for staff duress and patient management among other functions.
Lansitec, which offers a range of Bluetooth beacons, including badge-style transmitters, that are suitable for hospital asset tracking, staff location, and more, as well as a wide variety of other products. They emphasize features like adjustable transmit power and Angle of Arrival support for precise location.
MeshTrac, which offers BLE beacon-based tracking systems for patients and assets in healthcare, emphasizing real-time visibility, enhanced patient safety, and workflow optimization.
Minew, a significant manufacturer of BLE beacons and tags, including badge-style wearables designed for people management, staff tracking, and safety applications in various industries, including healthcare. Like Lansitec, they offer both standard and Angle of Arrival versions for improved accuracy.
Stanley Healthcare (AeroScout), a multinational company that is increasingly implementing BLE in its solutions, including for staff safety and for patient management.
Real-Time Location Services
'Real-time location services' is the name of the technology that makes locating a staff member in trouble, or determining that a patient is not in their room, possible. Real-time location services can be handled in a variety of ways in the healthcare: infrared, active and passive radio frequency identification (RFID), Wi-Fi, and ultra-wideband are all alternatives to BLE.
They each have pros and cons: While ultra-wideband is highly accurate, it's also generally much more expensive to deploy than BLE because it requires dedicated infrastructure and doesn't mesh as well with other systems; Wi-Fi, meanwhile, is cost-effective and easy to integrate but less precise and consumes more power; infrared systems can only achieve room-level accuracy because they generally can't penetrate walls; passive RFID tags are generally only useful for choke points like entries and exits, and active RFID tags require a battery but maintain a persistent signal so are less energy efficient than BLE.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

3 Healthcare Stocks Paying the Highest Dividends of 2025
3 Healthcare Stocks Paying the Highest Dividends of 2025

Yahoo

time25 minutes ago

  • Yahoo

3 Healthcare Stocks Paying the Highest Dividends of 2025

Key Points SIGA Technologies has a sky-high dividend yield that comes with a catch. Pfizer's dividend remains strong despite a looming patent cliff. Spok Holdings offers an attractive dividend and outstanding growth. 10 stocks we like better than Pfizer › The healthcare sector has long been a favorite for income investors -- and for good reason. Many healthcare stocks offer attractive dividend yields. Some stocks stand out more than others, though. Here are the three healthcare stocks paying the highest dividends in 2025. 1. SIGA Technologies SIGA Technologies (NASDAQ: SIGA) focuses primarily on developing drugs for treating orthopoxviruses. Its flagship product is TPOXX, an antiviral medication that's approved in the U.S. and Canada for treating smallpox and in Europe, Japan, and the U.K. for treating smallpox, mpox, cowpox, and vaccinia complications. The company's dividend yield is a lofty 9.29%. However, there's something investors should know about SIGA's dividend. The drugmaker doesn't pay a regular dividend but, instead, has declared special cash dividends for four consecutive years. Special cash dividends usually aren't viewed as favorably by income investors as established programs that pay dividends on a monthly or quarterly basis. The risk that a company will decide against paying a special cash dividend in the future is probably higher than the risk that a company will suspend a regular dividend. SIGA's ability to pay dividends in the future depends largely on how seriously governments perceive the threat posed by smallpox, mpox, and other orthopoxviruses. For now, the threat level is high. That probably bodes well for the company declaring a special cash dividend in 2026, but it's difficult to predict what will happen with SIGA's dividend beyond then. 2. Pfizer Pfizer (NYSE: PFE) is the most well-known of the high-paying healthcare dividend stocks on this list. The company was founded in 1849. Today, it's one of the biggest drugmakers on the planet, with a market cap of over $130 billion and a lineup that includes multiple blockbuster drugs. Income investors have a lot to like about Pfizer. Its forward dividend yield stands at 7.32%. The company has paid a dividend for 346 consecutive quarters and has increased its dividend for 16 consecutive years. Its management team remains committed to sustaining and growing the dividend. Pfizer faces some challenges that could limit how much it's able to increase the dividend over the next few years, though. By the end of 2028, the company will lose patent protection for kidney cancer drug Inlyta, autoimmune disease drug Xeljanz, blood thinner Eliquis, breast cancer drug Ibrance, prostate cancer drug Xtandi, rare-disease franchise Vyndaqel/Vyndamx, and Mektovi, which treats melanoma and non-small cell lung cancer. While this patent cliff admittedly looks daunting, Pfizer's dividend shouldn't be in danger. The drugmaker has several rising stars, including migraine therapy Nurtec ODT and cancer drugs Padcev, Lorbrena, and Elrexfio. Pfizer's pipeline is also loaded with promising candidates, including 30 late-stage programs. 3. Spok Holdings Spok Holdings (NASDAQ: SPOK) specializes in healthcare communication and collaboration solutions. The company's flagship product, Spok Care Connect, is a unified communication platform that provides closed-loop communication, secure messaging, and collaboration capabilities to clinical teams. While Spok mainly focuses on hospitals, it also sells products to large government agencies, public-safety institutions, academic institutions, and other commercial customers. There's good news and bad news with Spok's dividend. First, the bad news: Don't expect dividend increases. Spok hasn't increased its dividend since 2022. The good news, though, is that the dividend is attractive, with a forward yield of 6.75%. Want more good news? Spok's business is booming. The company's earnings jumped 33% year over year in the second quarter of 2025. Its software operations bookings were 34% higher than the prior-year period. Unsurprisingly, Spok's stock has also performed well and is handily beating the market so far this year. Should you buy stock in Pfizer right now? Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Pfizer wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* Now, it's worth noting Stock Advisor's total average return is 1,019% — a market-crushing outperformance compared to 178% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Keith Speights has positions in Pfizer. The Motley Fool has positions in and recommends Pfizer. The Motley Fool has a disclosure policy. 3 Healthcare Stocks Paying the Highest Dividends of 2025 was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

How to Stay Safe as Smoky Air Blankets US
How to Stay Safe as Smoky Air Blankets US

Bloomberg

time28 minutes ago

  • Bloomberg

How to Stay Safe as Smoky Air Blankets US

Hi! It's Madison in New York. If you've found it harder to breathe recently, you're not alone. But first... A couple months ago, I noticed that I was coughing a lot on my weekly runs. I've been running for years and I'm currently training for my third marathon, so it wasn't the result of simply being out-of-shape. Before long, I realized my cough was much worse on days when the air quality in New York was particularly bad. Recently, that's felt like more and more often.

FDA grants conditional approval for TransMedics' OCS ENHANCE Heart trial
FDA grants conditional approval for TransMedics' OCS ENHANCE Heart trial

Yahoo

timean hour ago

  • Yahoo

FDA grants conditional approval for TransMedics' OCS ENHANCE Heart trial

The US Food and Drug Administration (FDA) has conditionally approved TransMedics Group's investigational device exemption (IDE) to commence the next-generation OCS ENHANCE Heart study. Part A of the trial will focus on supporting prolonged heart perfusion leveraging the OCS Heart System. OCS Heart comprises a portable, warm perfusion system, which is said to maintain a donor heart in a metabolically active state, allowing physicians to monitor and assess the heart's condition and viability. Part B aims to demonstrate the OCS Heart perfusion's superiority in donation after brain death (DBD) cases over traditional static cold storage methods. This part is aimed at supporting the potential expansion of the system use for DBD hearts, which are currently ineligible for OCS perfusion and preservation. The anticipated sample size for both parts of the trial is set to exceed 650 subjects, which the company believes would make the largest heart preservation for transplant trial ever worldwide. TransMedics Group CEO and president Waleed Hassanein said: "The recent FDA approvals to initiate our Next-Gen OCS ENHANCE Heart and DENOVO Lung trials mark key milestones in our ongoing commitment to transforming the standard of care and addressing the major clinical needs of the cardiothoracic transplant community. "We are thrilled to be in a position to initiate both trials in the fourth quarter of 2025 while we continue to work collaboratively with the FDA to address any remaining questions related to pre-clinical testing. 'As I have stated before, we hope these two trials will be major catalysts for clinical adoption for both heart and lung throughout 2026 and beyond." In 2023, the company completed the acquisition of a premier US charter flight operator, Summit Aviation. This move has established TransMedics Aviation as the first dedicated national air logistics provider exclusively for organ transplantation in the US. "FDA grants conditional approval for TransMedics' OCS ENHANCE Heart trial" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Connectez-vous pour accéder à votre portefeuille

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store